Bringing back Vinyl: company recreates records from original masters

first_imgEbola: Nigeria Records 7 Deaths Related Company uses robots to care for the elderly Top Tyre company shuts down production in Kenya These days, every major label and many smaller ones are releasing vinyl, and most major new releases have a vinyl version, leading to a spate of new pressing plants These days, every major label and many smaller ones are releasing vinyl, and most major new releases have a vinyl version, leading to a spate of new pressing plantsVinyl is emphatically back in vogue as a London company, using 50s technology, is recreating records from original masters. And it’s finding willing buyers in China and elsewhere in East Asia.The Electric Recording Company recreates the original quality of famous LPs, and though it’s been a painstaking process, it has also been a very rewarding one, CCTV’s Catherine Drew reports.last_img read more

Continue Reading

Gridiron: The year of the upset

first_imgThe first four weeks of the college football season have been filled with teeth-grinding finishes and shocking results. Teams that began the ’07 campaign with BCS bowl aspirations have already fallen out of legitimate contention and teams merely striving for some sort of postseason appearance are now undefeated and in the mix with the elite. Let’s take a look at some of the early surprises from around the nation:Stock RisingNo. 11 Oregon (4-0, 1-0)USC and Cal aren’t the only Pac-10 high-flying offenses dominating opponents thus far. Unranked at the season’s beginning, the now-No. 11 Oregon Ducks are showing critics across the nation that they too should be considered Pac-10 Championship contenders. Senior quarterback Dennis Dixon has executed the spread offense to perfection, which still gives fans in Ann Arbor, Mich. nightmares after the Ducks dismantled the Wolverines 39-7 in week two. Dixon has thrown for 11 touchdowns and run for four to lead the Ducks’ offense, which is averaging 48.5 points and 536.8 total yards per game. Junior running back Jonathan Stewart has led the Ducks’ rushing attack with 503 yards and four touchdowns while boasting a ridiculous 7.7 yards per rush.The Ducks will be tested this week when No. 6 California comes to town. But a win against the Golden Bears at home Saturday will solidify a spot in everyone’s top 10.No. 12 Boston College. (4-0, 3-0)Most teams schedule their nonconference matchups for the first three weeks of the season. Not Boston College. The Eagles took on the defending ACC champion Wake Forest Demon Deacons in week one, then beat North Carolina State at home before taking down then-ranked Georgia Tech in Atlanta. These impressive conference victories are why the Eagles have gone from being unranked to No. 12. Senior quarterback Matt Ryan has quickly become a darkhorse Heisman Trophy candidate, as he is on pace for over 4,000 yards passing and 30 touchdowns this season.The Eagles have to travel to No. 17 Virginia Tech Oct. 25, but get No. 13 Clemson at home Nov. 17. If Ryan can stay this consistent, the Eagles should be the favorites to succeed the Deacons as ACC champs, which would give them an automatic bid into the FedEx Orange Bowl.No. 14 Kentucky (4-0, 1-0)Senior quarterback Andre’ Woodson may be the best player in the nation most people have never heard of, and he will quite likely be a first round draft pick in the 2008 NFL draft. Woodson has led the Wildcats to back-to-back upset victories over then-No. 9 Louisville at home and Arkansas on the road. Woodson has thrown 6 touchdowns and no interceptions in those two games (11 TD, 0 INT on the season).Senior running back Rafael Little has rushed for 435 yards and 3 touchdowns while averaging 7.0 yards per rush.After facing Florida Atlantic this week, the Wildcats have to face No. 16 South Carolina, No. 4 Florida and No. 2 LSU in consecutive weeks. It doesn’t get much more brutal than that. Good thing Kentucky is playing some of the best football in the country right now.Stock FallingGeorgia Tech (2-2, 0-2)After starting 2-0 and climbing to No. 15 in the Associated Press Poll, the Yellow Jackets have dropped their last two games, both against ACC opponents. Georgia Tech lost to Boston College by 14 points at home and then got beat by a mediocre Virginia team on the road. Junior quarterback Taylor Bennett has been ineffective in the two Yellow Jacket losses, throwing for just one touchdown and one interception while completing less than 50 percent of his passes. The Tech defense hasn’t been much to brag about either, as it has given up 26.0 points per game in ACC play. No one has been able to fill the void that No. 2 overall pick Calvin Johnson left in Atlanta, either. Sophomore wideout Greg Smith leads the team with only 181 yards on 14 catches in four games.The road doesn’t get any easier for the Jackets, as they host No. 13 Clemson this week. However, a victory over the Tigers would certainly project them in the right direction.Louisville (2-2, 0-1)The Louisville Cardinals may be the most disappointing team in the country thus far. After being ranked as high at No. 9, Louisville has dropped two straight, falling completely out of the Top 25. A 40-34 loss against a solid Kentucky team on the road in week three wasn’t a total catastrophe, but a 38-35 loss to Syracuse (who may be the worst team in the Big East) at home was.Although senior quarterback Brian Brohm will likely still be selected in the first round of next April’s draft, he can kiss the Heisman Trophy goodbye. Although he has put up impressive numbers (1,697 yards, 15 touchdowns), it hasn’t been enough for the Louisville defense (giving up 37.0 points per game over the last three games) to withstand.With four games against currently ranked teams still on its schedule (No. 24 Cincinnati, No. 5 West Virginia, No. 18 South Florida, No. 10 Rutgers), Louisville’s chances of a Big East Championship are rapidly diminishing, unless the Cardinals’ defense drastically improves.Arkansas (1-2, 0-2)Despite losing to Wisconsin in last season’s Capitol One Bowl, many thought Arkansas could compete with LSU for an SEC West Championship. But after losing back-to-back games to Alabama and Kentucky, the Razorbacks sit at the bottom of the division standings.Explosive running backs Felix Jones and Darren McFadden have lived up to their end of the bargain, combining for 877 yards rushing and five touchdowns in just three games. But the Razorback defense has been atrocious, giving up 83 points over its last two games, plus another 26 to Troy in week one.With a schedule that lacks a matchup against Florida this season, Arkansas has done everything to not take of their boon. They still have to travel to Baton Rouge to take on an LSU team that could very well be playing for a National Championship in January. Needless to say, the future is not bright in Fayetteville, Ark.last_img read more

Continue Reading

Brazils dengue vaccine in jeopardy

first_img Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Experts worry that firing of director could impact the Butantan Institute’s dengue vaccine efforts. Brazil’s dengue vaccine in jeopardy Email Click to view the privacy policy. Required fields are indicated by an asterisk (*) By Herton EscobarFeb. 28, 2017 , 12:15 PMcenter_img SÃO PAULO, BRAZIL—A promising dengue vaccine faces an uncertain future in Brazil, scientists say, after the dismissal of a prominent immunologist who has been overseeing clinical trials of the preparation here.  Last week, the São Paulo state government removed Jorge Kalil as director of the Butantan Institute, following accusations of administrative wrongdoing leveled against him by a former colleague. Announcing Kalil’s dismissal on 21 February, Governor Geraldo Alckmin praised him as a “great scientist” and said he wished he would continue to lead Butantan’s dengue vaccine program. Kalil told ScienceInsider he will decline that invitation. He denies the accusations against him and says it’s impossible to continue leading the vaccine program from outside the institute. “This is not an isolated project; it’s something that requires a coordinated effort by the entire institution,” he says. “I can’t accept something like this.”Scientists here and abroad have protested Kalil’s dismissal. Butantan researchers and staff staged protests last week, and the institute’s influenza vaccine factory shut down for a half day on Friday, demanding his return. In a 23 February letter to Governor Alckmin, Anna Durbin of the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, who led the initial clinical trials of the vaccine, wrote that the dengue vaccine program made “tremendous progress” under Kalil, and that this momentum may be “reversed by the removal of his leadership of the Butantan Institute.” Sign up for our daily newsletter Get more great content like this delivered right to you! Country CAMILLA CARVALHO/INSTITUTO BUTANTAN The U.S. National Institute of Allergy and Infectious Diseases (NIAID) developed the early version of the TV003 vaccine—designed to protect against all four serotypes of the dengue virus—and sponsored the initial clinical trials, which were completed in 2012. NIAID then licensed the preparation to the Butantan Institute, a state-owned biomedical research and vaccine production facility here, to further develop the vaccine and conduct clinical trials in Brazil, where dengue fever is an endemic threat. The Butantan-produced vaccine is now being tested at 14 institutions across the country, in a $100 million, phase III randomized trial sponsored by Brazil’s federal government.Stephen Whitehead, a senior associate scientist at NIAID who led development of the vaccine’s attenuated viruses, also wrote to Alckmin, arguing that Kalil’s leadership skills were “essential” to the program’s continuation and that his removal from Butantan could have “dire public health consequences for the State of São Paulo and Brazil.” “His ability to solicit support for sound scientific endeavors, develop the framework for their realization, and reach out for international partners is indispensable for the success and credibility of the institute,” Whitehead wrote.Brazilian scientific organizations have also lobbied on Kalil’s behalf. In a public letter to Alckmin released on 22 February, the Brazilian Society for the Advancement of Science and the Brazilian and São Paulo academies of sciences ask that “apparent political conflicts of interest involved in this crisis do not interrupt projects that are so relevant to Brazil and the world”.In statements to the press, the São Paulo State Health Secretariat stated that Kalil was fired because of “grave administrative problems” detected at the institute during this tenure—he has been director since 2011—and for not respecting hierarchy.Kalil believes his removal resulted from personal and political motivations. He says he will refocus now on his other appointments at the University of São Paulo’s Medical School and Heart Institute, where he is a senior professor of immunology.Alckmin has appointed Dimas Tadeu Covas, a professor of hematology at the University of São Paulo’s Ribeirão Preto Medical School, as Butantan’s new director. “I do hope the person selected to lead the dengue vaccine program understands the immense effort it takes to see a vaccine through,” Durbin wrote in an email to ScienceInsider.*Update, 3 March, 2:39 p.m.: In a 2 March statement, the Health Secretariat of the São Paulo state government declared that “the development of the tetravalent dengue vaccine and other research projects of the [Butantan] Institute will not be affected by the exit of professor Jorge Kalil.” It further stated that “Butantan will remain strong as an international center of excellence in science, culture and public health.last_img read more

Continue Reading